XWELL, Inc. (XWEL)
(Delayed Data from NSDQ)
$1.65 USD
+0.04 (2.48%)
Updated Sep 16, 2024 03:59 PM ET
After-Market: $1.65 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
XWELL, Inc. [XWEL]
Reports for Purchase
Showing records 1 - 7 ( 7 total )
Company: XWELL, Inc.
Industry: Medical Services
Company: XWELL, Inc.
Industry: Medical Services
3Q23 Results Disappoint; More MA Likely Required to Scale Revenue Over Coming Quarters; Reit. Buy; PT Up To $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
Company: XWELL, Inc.
Industry: Medical Services
Extension with CDC a Clear Positive, Potential MA Could be Meaningful Catalyst For Revenue Growth; Reit Buy, $1.00 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
Company: XWELL, Inc.
Industry: Medical Services
Revenue Largely In-Line, Shares Trading Under Cash Value, But Growth Outlook Remains Uncertain; Reit Buy, $1.00 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
Company: XWELL, Inc.
Industry: Medical Services
No Surprise as Revenue Consistent with Preliminary, Significant Value in the Business Keep Us Engaged; Reit. Buy, $1 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
Company: XWELL, Inc.
Industry: Medical Services
Adjusting Model to Reflect Preliminary 4Q22 Results, Business Visibility Still a Challenge; Reit. Buy, PT Down to $1.00
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
Company: XWELL, Inc.
Industry: Medical Services
Tough Qtr as Business Transitions Away From Testing, Visibility Somewhat Uncertain Given Macro; Reit Buy, PT to $1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
|